Virtual reality for pain management in advanced heart failure: A randomized controlled study.

MedStar author(s):
Citation: Palliative Medicine. 35(10):2008-2016, 2021 Dec.PMID: 34431398Institution: MedStar Health Research Institute | MedStar Health Research Instituteihriye | MedStar Institute for Innovation | MedStar Washington Hospital CenterDepartment: Medicine/Palliative Care | PharmacyForm of publication: Journal ArticleMedline article type(s): Journal ArticleSubject headings: *Chronic Pain | *Heart Failure | *Virtual Reality | Heart Failure/th [Therapy] | Humans | Pain Management | Prospective StudiesYear: 2021Local holdings: Available online from MWHC library: 1996 - presentISSN:
  • 0269-2163
Name of journal: Palliative medicineAbstract: AIM: To investigate the impact of a virtual reality experience on self-reported pain, quality-of-life, general distress, and satisfaction compared to a two-dimensional guided imagery active control.BACKGROUND: Hospitalized patients with advanced heart failure often experience acute and/or chronic pain. While virtual reality has been extensively studied across a wide range of clinical settings, no studies have yet evaluated potential impact on pain management on this patient population.CONCLUSION: Virtual reality may be an effective nonpharmacologic adjuvant pain management intervention in hospitalized patients with heart failure.DESIGN: Single-center prospective randomized controlled study. The primary outcome was the difference in pre- versus post-intervention self-reported pain scores on a numerical rating scale from 0 to 10. Secondary outcomes included changes in quality-of-life scores, general distress, and satisfaction with the intervention.RESULTS: Participants experienced significant improvement in pain score after either 10 minutes of virtual reality (change from pre- to post -2.9 +/- 2.6, p < 0.0001) or 10 minutes of guided imagery (change from pre- to post -1.3 +/- 1.8, p = 0.0001); the virtual reality arm experienced a 1.5 unit comparatively greater reduction in pain score compared to guided imagery (p = 0.0011). Total quality-of-life and general distress scores did not significantly change for either arm. Seventy-eight participants (89%) responded that they would be willing to use the assigned intervention again.SETTING/PARTICIPANTS: Between October 2018 and March 2020, 88 participants hospitalized with advanced heart failure were recruited from an urban tertiary academic medical center.TRIAL REGISTRATION: ClinicalTrials.gov database (NCT04572425).All authors: Cowgill J, Fisher JM, Groninger H, Mete M, Stewart D, Tefera EOriginally published: Palliative Medicine. 35(10):2008-2016, 2021 Dec.Fiscal year: FY2022Fiscal year of original publication: FY2022Digital Object Identifier: ORCID: Date added to catalog: 2021-11-01
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 34431398 Available 34431398

Available online from MWHC library: 1996 - present

AIM: To investigate the impact of a virtual reality experience on self-reported pain, quality-of-life, general distress, and satisfaction compared to a two-dimensional guided imagery active control.

BACKGROUND: Hospitalized patients with advanced heart failure often experience acute and/or chronic pain. While virtual reality has been extensively studied across a wide range of clinical settings, no studies have yet evaluated potential impact on pain management on this patient population.

CONCLUSION: Virtual reality may be an effective nonpharmacologic adjuvant pain management intervention in hospitalized patients with heart failure.

DESIGN: Single-center prospective randomized controlled study. The primary outcome was the difference in pre- versus post-intervention self-reported pain scores on a numerical rating scale from 0 to 10. Secondary outcomes included changes in quality-of-life scores, general distress, and satisfaction with the intervention.

RESULTS: Participants experienced significant improvement in pain score after either 10 minutes of virtual reality (change from pre- to post -2.9 +/- 2.6, p < 0.0001) or 10 minutes of guided imagery (change from pre- to post -1.3 +/- 1.8, p = 0.0001); the virtual reality arm experienced a 1.5 unit comparatively greater reduction in pain score compared to guided imagery (p = 0.0011). Total quality-of-life and general distress scores did not significantly change for either arm. Seventy-eight participants (89%) responded that they would be willing to use the assigned intervention again.

SETTING/PARTICIPANTS: Between October 2018 and March 2020, 88 participants hospitalized with advanced heart failure were recruited from an urban tertiary academic medical center.

TRIAL REGISTRATION: ClinicalTrials.gov database (NCT04572425).

English

Powered by Koha